Drug intelligence / Profile preview

StayBred

Development stage
Preclinical
Lead developer
AspenBio Pharma
Modality
Recombinant Proteins and Enzymes
Administration
Intramuscular
01

Overview

StayBred is a veterinary biologic developed by AspenBio Pharma, Inc. (now Venaxis) that consists of a recombinant single-chain luteinizing hormone (LH) analog. Designed specifically for use in dairy cows, the drug aims to improve reproductive efficiency by assisting in pregnancy maintenance. By mimicking the biological activity of natural luteinizing hormone, StayBred supports the corpus luteum and progesterone production, which are essential for sustaining a successful pregnancy. The product was developed to increase milk production and reduce the economic costs associated with reproductive failure in bovine species. AspenBio Pharma filed an Investigational New Animal Drug Application (INADA) for StayBred with the FDA in 2007.

Brand names
StayBred
Other names
recombinant single-chain luteinizing hormone analogrecombinant bovine luteinizing hormone
02

Targets

LHCGR (Luteinizing hormone/choriogonadotropin receptor)

Beyond the preview

Go deeper on StayBred.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on StayBred.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call